Suppr超能文献

基于人体测量学的儿童期生长激素分泌生化检测临界值

Auxology-based cut-off values for biochemical testing of GH secretion in childhood.

作者信息

Binder G, Huller E, Blumenstock G, Schweizer R

机构信息

University-Children's Hospital, Pediatric Endocrinology, Tuebingen, Germany.

出版信息

Growth Horm IGF Res. 2011 Aug;21(4):212-8. doi: 10.1016/j.ghir.2011.05.007. Epub 2011 Jun 14.

Abstract

OBJECTIVE

The diagnosis of GH deficiency (GHD) in childhood requires GH tests with arbitrary cut-offs. We aimed to define GH cut-offs based on auxology.

DESIGN

From a total of 349 children diagnosed with GHD between 1985 and 2005 at our hospital, we excluded all children who had additional characteristics likely to interfere with growth velocity. Age at start of therapy was defined as 4 to 8/9 years (girls/boys). Auxological inclusion criteria were pathological growth velocity, height at start of therapy >1.5 SD below the target, and efficient catch-up growth during GH therapy. Basal IGF-I/IGFBP-3, GH response to arginine and spontaneous GH secretion at night had been measured by the same polyclonal RIA. The reference was a group of 108 normally growing age-matched children with Turner syndrome or born small for gestational age tested during the same time period.

RESULTS

We identified 52 children with GHD who fulfilled the inclusion criteria. ROC analysis showed the best diagnostic accuracy at a peak GH cut-off for arginine of 6.6 μg/L (sensitivity, 84.3%; specificity, 75.5%; AUC=0.83) and at a peak GH cut-off during spontaneous secretion at night of 7.3 μg/L (sensitivity, 96.8%; specificity, 82.4%; AUC=0.93). Our arbitrarily defined GH cut-offs had been higher. Children diagnosed with GHD in the past with GH test values above the new cut-offs were less responsive to GH therapy (P=0.007).

CONCLUSIONS

Here we provide a new rational approach which allows the substitution of arbitrarily defined GH cut-offs by those based on auxology.

摘要

目的

儿童生长激素缺乏症(GHD)的诊断需要采用具有任意临界值的生长激素检测。我们旨在根据儿童生长学确定生长激素临界值。

设计

在我院1985年至2005年间诊断为GHD的349名儿童中,我们排除了所有可能干扰生长速度的其他特征的儿童。治疗开始时的年龄定义为4至8/9岁(女孩/男孩)。儿童生长学纳入标准为病理性生长速度、治疗开始时身高低于目标值1.5标准差以上,以及生长激素治疗期间有效的追赶生长。基础胰岛素样生长因子-I/胰岛素样生长因子结合蛋白-3、精氨酸刺激后的生长激素反应以及夜间自发性生长激素分泌均采用相同的多克隆放射免疫分析法进行测定。对照组为同期检测的108名年龄匹配、生长正常的特纳综合征儿童或小于胎龄儿。

结果

我们确定了52名符合纳入标准的GHD儿童。ROC分析显示,精氨酸刺激后生长激素峰值临界值为6.6μg/L时诊断准确性最佳(敏感性84.3%;特异性75.5%;AUC=0.83),夜间自发性分泌时生长激素峰值临界值为7.3μg/L时诊断准确性最佳(敏感性96.8%;特异性82.4%;AUC=0.93)。我们之前任意定义的生长激素临界值更高。过去生长激素检测值高于新临界值而被诊断为GHD的儿童对生长激素治疗的反应较差(P=0.007)。

结论

我们在此提供了一种新的合理方法,可将基于任意定义的生长激素临界值替换为基于儿童生长学的临界值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验